V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001877 | 240001877 | 1.71 | 77.6 | Curative (C) | null | 2016-07-30 | null | 02 | N | TRIPLE INTRATHECAL | 100172582 |
| 240001886 | 240001886 | 1.62 | 0 | Curative (C) | null | 2018-10-20 | null | N | N | CYTARABINE + DAUNORUBICIN | 100595280 |
| 240001887 | 240001887 | null | null | null | null | 2018-06-01 | DA | null | null | GEMTUZUMAB OZOGAMICIN | 101798859 |
| 240001889 | 240001889 | 1.62 | 76.5 | Curative (C) | null | 2017-07-11 | CHOP R - 21 days | 02 | N | HYDROXYCARBAMIDE | 100137524 |
| 240001891 | 240001891 | 1.68 | 104 | Curative (C) | null | 2017-01-18 | null | 02 | N | AML16 TRIAL | 101526258 |
| 240001892 | 240001892 | 1.76 | null | Curative (C) | null | 2019-08-29 | null | 02 | N | HYDROXYCARBAMIDE | 100899672 |
| 240001896 | 240001896 | 1.6 | 91 | Curative (C) | null | 2016-12-07 | null | N | N | MITOXANTRONE | 101542576 |
| 240001899 | 240001899 | null | null | null | null | 2017-09-05 | null | null | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100190848 |
| 240001902 | 240001902 | 1.8 | 75.8 | 03 | null | 2017-04-16 | CYTARABINE + DAUNORUBICIN | N | N | CHOP R | 100756835 |
| 240001912 | 240001912 | 1.65 | 73 | Palliative (P) | 2019-09-15 | 2019-09-16 | AML 19 TRIAL | 02 | N | TRIAL | 100060591 |
| 240001919 | 240001919 | null | null | null | null | 2019-03-19 | Trial Unspecified | null | null | CHOP R | 100137090 |
| 240001924 | 240001924 | null | null | null | null | 2018-02-20 | Bendamustine+Rituximab (1st Course) | null | null | HYDROXYCARBAMIDE | 100864885 |
| 240001925 | 240001925 | 1.69 | 10.35 | Curative (C) | 2016-10-20 | 2016-10-21 | null | 02 | N | AZACITIDINE | 100209018 |
| 240001931 | 240001931 | null | null | null | null | 2018-07-16 | Arsenic trioxide + Tretinoin | null | null | AML19 TRIAL | 101469562 |
| 240001934 | 240001934 | 1.79 | 101.6 | 03 | null | 2019-10-12 | CHOP R - 21 days | N | N | CHOP R | 101579899 |
| 240001937 | 240001937 | 1.57 | null | Adjuvant (A) | 2020-03-09 | 2020-03-09 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101007154 |
| 240001938 | 240001938 | null | null | null | null | 2016-06-16 | AML 18 TRIAL | null | null | CHLORAMBUCIL + OBINUTUZUMAB | 100856764 |
| 240001941 | 240001941 | null | null | null | null | 2017-03-21 | CYTARABINE + DAUNORUBICIN | null | null | HYDROXYCARBAMIDE | 101735965 |
| 240001943 | 240001943 | null | null | null | null | 2019-10-22 | null | null | null | AML19 TRIAL | 100562552 |
| 240001944 | 240001944 | null | null | null | null | 2016-03-04 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100574716 |
| 240001945 | 240001945 | 1.65 | 78.2 | Curative (C) | null | 2018-02-07 | BENDAMUSTINE + RITUXIMAB | 01 | Y | HYDROXYCARBAMIDE | 101112766 |
| 240001948 | 240001948 | 1.8 | 83.4 | Disease modification (D) | 2017-03-23 | 2017-03-28 | Bevacizumab+Carbo+Pacliaxel | 02 | N | AZACITIDINE | 100575517 |
| 240001950 | 240001950 | null | null | null | null | 2018-10-24 | null | null | null | TRIAL | 101147425 |
| 240001951 | 240001951 | 1.71 | 96.9 | Curative (C) | null | 2017-05-19 | Cytarabine Low Dose | N | N | BENDAMUSTINE + RITUXIMAB | 100267105 |
| 240001952 | 240001952 | null | null | null | null | 2016-11-08 | null | null | null | AML19 TRIAL | 100052028 |
| 240001954 | 240001954 | 1.51 | 64.4 | Curative (C) | 2019-03-26 | 2019-04-01 | AML 18 TRIAL | null | N | DA | 101393209 |
| 240001955 | 240001955 | 0.93 | 10.4 | Curative (C) | 2016-01-27 | 2016-01-27 | AML 19 TRIAL | 02 | N | HYDROXYCARBAMIDE | 101150207 |
| 240001962 | 240001962 | null | null | null | null | 2016-04-24 | null | null | null | AZACITIDINE | 100563728 |
| 240001968 | 240001968 | 1.71 | 68.4 | Palliative (P) | null | 2016-10-24 | null | 02 | N | CHLORAMBUCIL | 101717287 |
| 240001969 | 240001969 | 1.6 | null | Palliative (P) | null | 2016-06-14 | IMATINIB | 02 | N | BENDAMUSTINE + CYTARABINE + RITUXIMAB | 100178601 |
| 240001985 | 240001985 | 1.73 | 55.8 | Palliative (P) | null | 2019-05-06 | AML 19 TRIAL | 02 | N | HYDROXYCARBAMIDE | 100050227 |
| 240001987 | 240001987 | null | null | null | null | 2017-09-18 | null | null | null | BENDAMUSTINE + RITUXIMAB | 101583704 |
| 240001991 | 240001991 | 1.7 | 69.5 | Curative (C) | null | 2016-01-15 | AML 19 TRIAL | 02 | N | AZACITIDINE | 100314498 |
| 240002002 | 240002002 | 1.67 | null | Neo-adjuvant (N) | null | 2018-07-14 | AML 18 TRIAL | 02 | N | AML18 TRIAL | 101736448 |
| 240002005 | 240002005 | 1.82 | null | Curative (C) | 2019-03-03 | 2019-03-16 | AML16 Azacitidine | null | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100778301 |
| 240002007 | 240002007 | 1.66 | 82 | 03 | null | 2016-03-21 | null | 02 | N | GEMTUZUMAB OZOGAMICIN | 100038688 |
| 240002023 | 240002023 | 1.77 | 73.1 | Curative (C) | null | 2019-09-28 | Hydroxycarbamide | 02 | N | METHOTREXATE INTRATHECAL | 101250357 |
| 240002026 | 240002026 | 1.7 | 99.8 | Curative (C) | null | 2019-06-04 | CHOP R - 21 days | 1 | N | BENDAMUSTINE + RITUXIMAB | 100666042 |
| 240002028 | 240002028 | 1.78 | 60 | Adjuvant (A) | 2017-04-15 | 2017-04-16 | null | 01 | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100853005 |
| 240002034 | 240002034 | 1.7 | 162.7 | Palliative (P) | null | 2018-03-11 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100494626 |
| 240002041 | 240002041 | 1.6 | 101.6 | Palliative (P) | null | 2018-03-24 | DA | 02 | N | DA | 100438538 |
| 240002042 | 240002042 | null | null | null | null | 2017-03-14 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100309740 |
| 240002050 | 240002050 | 1.77 | 79.2 | Curative (C) | null | 2019-10-03 | null | 02 | N | METHOTREXATE | 101666654 |
| 240002056 | 240002056 | 1.78 | 65.8 | Curative (C) | null | 2015-02-27 | AML 19 TRIAL | N | N | NOT MATCHED | 101235252 |
| 240002058 | 240002058 | 1.64 | 10.4 | Curative (C) | 2019-02-14 | 2019-02-15 | Hydroxycarbamide | N | null | TRIAL | 100511822 |
| 240002059 | 240002059 | 1.88 | 74 | Curative (C) | null | 2019-01-09 | AML 19 TRIAL | 02 | Y | CLADRIBINE + RITUXIMAB | 100356495 |
| 240002062 | 240002062 | 1.54 | null | Curative (C) | 2018-09-06 | 2018-09-12 | AML 18 TRIAL | 02 | N | DA | 101172936 |
| 240002070 | 240002070 | 1.71 | 76.2 | Palliative (P) | null | 2018-05-02 | null | 02 | Y | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100340604 |
| 240002077 | 240002077 | 1.56 | 63.8 | Curative (C) | 2018-03-20 | 2018-03-20 | Cladribine (subcut) 5 days | 02 | N | AML19 TRIAL | 101468455 |
| 240002078 | 240002078 | 1.86 | 78.5 | Curative (C) | null | 2017-06-13 | null | N | N | HYDROXYCARBAMIDE | 101500790 |